Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective

Brian Godman, Eleonora Allocati, Evelien Moorkens

Research output: Contribution to journalEditorial

Abstract

Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.
LanguageEnglish
Number of pages7
JournalGenerics and Biosimilars Initiative journal
Volume8
Issue number3
Early online date25 Sep 2019
Publication statusE-pub ahead of print - 25 Sep 2019

Fingerprint

Biosimilar Pharmaceuticals
Canada

Keywords

  • biosimilars
  • Canada
  • reimbursement
  • health policies

Cite this

@article{2ed011743ffc4e93b1c78df1db987eb2,
title = "Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective",
abstract = "Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.",
keywords = "biosimilars, Canada, reimbursement, health policies",
author = "Brian Godman and Eleonora Allocati and Evelien Moorkens",
year = "2019",
month = "9",
day = "25",
language = "English",
volume = "8",
journal = "Generics and Biosimilars Initiative journal",
issn = "2033-6403",
number = "3",

}

Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective. / Godman, Brian; Allocati, Eleonora ; Moorkens, Evelien .

In: Generics and Biosimilars Initiative journal, Vol. 8, No. 3, 25.09.2019.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective

AU - Godman, Brian

AU - Allocati, Eleonora

AU - Moorkens, Evelien

PY - 2019/9/25

Y1 - 2019/9/25

N2 - Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.

AB - Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.

KW - biosimilars

KW - Canada

KW - reimbursement

KW - health policies

UR - http://gabi-journal.net/ever-changing-landscape-of-biosimilars-in-canada-findings-and-implications-from-a-global-perspective.html

M3 - Editorial

VL - 8

JO - Generics and Biosimilars Initiative journal

T2 - Generics and Biosimilars Initiative journal

JF - Generics and Biosimilars Initiative journal

SN - 2033-6403

IS - 3

ER -